We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNMD icon
1326
CONMED
CNMD
$1.47B
– –
-525
Closed -$50K
COHR icon
1327
Coherent
COHR
$74.2B
– –
-64,289
Closed -$2.26M
COHU icon
1328
Cohu
COHU
$2.5B
– –
-37,600
Closed -$508K
COLM icon
1329
Columbia Sportswear
COLM
$2.94B
– –
-1,894
Closed -$184K
CRH icon
1330
CRH
CRH
$66.8B
– –
-143,596
Closed -$4.93M
CRL icon
1331
Charles River Laboratories
CRL
$12.8B
– –
-27,777
Closed -$3.68M
CRNX icon
1332
Crinetics Pharmaceuticals
CRNX
$8.92B
– –
-2,965
Closed -$45K
CSTL icon
1333
Castle Biosciences
CSTL
$979M
– –
-24,524
Closed -$444K
CTMX icon
1334
CytomX Therapeutics
CTMX
$754M
– –
-3,436
Closed -$25K
CTRE icon
1335
CareTrust REIT
CTRE
$9.74B
– –
-26,911
Closed -$632K
CUBE icon
1336
CubeSmart
CUBE
$9.41B
– –
-8,371
Closed -$292K
CVI icon
1337
CVR Energy
CVI
$3.13B
– –
-1,296
Closed -$57K
CVLT icon
1338
Commault Systems
CVLT
$5.61B
– –
-929
Closed -$42K
CVNA icon
1339
Carvana
CVNA
$77.9B
– –
-29,975
Closed -$396K
CXT icon
1340
Crane NXT
CXT
$3.07B
– –
-74,943
Closed -$2.1M
DAVA icon
1341
Endava
DAVA
$156M
– –
-333
Closed -$13K
DB icon
1342
Deutsche Bank
DB
$71.5B
– –
-6,774
Closed -$51K
DBI icon
1343
Designer Brands
DBI
$333M
– –
-3,048
Closed -$52K
DELL icon
1344
Dell
DELL
$293B
– –
-700,853
Closed -$18.4M
DFS
1345
DELISTED
Discover Financial Services
DFS
– –
-51,594
Closed -$4.18M
DGII icon
1346
Digi International
DGII
$3.1B
– –
-8,660
Closed -$118K
DHI icon
1347
D.R. Horton
DHI
$42.3B
– –
-78,077
Closed -$4.12M
DPZ icon
1348
Domino's
DPZ
$11.6B
– –
-3
Closed -$1K
DRI icon
1349
Darden Restaurants
DRI
$24.4B
– –
-80,451
Closed -$9.51M
DSGX icon
1350
Descartes Systems
DSGX
$6.82B
– –
-10,029
Closed -$405K
52 53
54
55 56

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.